首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1705688

功能服務供應商(FSP) 市場按服務類型、階段、治療領域、最終用戶和地區分類

Functional Service Providers (FSP) Market, By Service Type, By Stage, By Therapeutic Area, By End User, By Geography

出版日期: 2025年02月21日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球功能服務供應商(FSP) 市場規模為 184 億美元，到 2032 年將達到 328 億美元，2025 年至 2032 年的複合年成長率為 8.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	184億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	8.60%	2032年價值預測	328億美元

數字。 2025 年各地區功能服務供應商(FSP)市場佔有率（%）

功能服務供應商(FSP) 旨在透過代表企業管理各種後端和管理功能，使企業能夠專注於其核心業務活動。 FSP 處理非核心但重要的業務職能，例如財務和會計、人力資源、採購和供應鏈管理。這使得客戶能夠以經濟高效的方式擴展業務，而無需投資大規模的內部能力開發。它還有助於提高業務效率和最佳化成本。市場為企業提供了利用專業知識和技術來改進各種功能流程的機會。

市場動態：

功能服務供應商市場的成長是由擴大採用外包作為降低業務成本和獲得領域專業知識的策略所推動的。許多公司希望與 FSP 合作，以便能夠靈活地擴展業務以滿足不斷變化的業務需求。對失去某些職能控制權的擔憂，以及在關鍵業務上過度依賴外部合作夥伴的風險，被視為市場限制。然而，自動化技術的進步和創新經營模式的出現等因素正在為該行業創造新的機會。供應商正在利用分析、人工智慧和區塊鏈等技術開發特定於產業和功能的解決方案。例如，2022 年 9 月，區塊鏈整合電子臨床平台供應商 Triall 與梅奧診所的研究人員合作，推動臨床試驗設計和資料管理技術。此次合作標誌著引領全球向分散臨床研究轉型邁出了重要一步。

本研究的主要特點

本報告對全球功能服務供應商(FSP) 市場進行了詳細分析，並展示了預測期 (2025-2032) 的市場規模（以十億美元為單位）和複合年成長率，假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球功能服務供應商(FSP) 市場中的主要企業是根據以下參數列出的，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
研究中介紹的主要企業包括 IQVIA、Parexel International Corporation、ICON plc、PRA Health Sciences、Covance Inc.、Charles River Laboratories International Inc.、Syneos Health、Pharmaceutical Product Development LLC (PPD)、Medpace Holdings Inc.、LabCorp、無錫藥明康德、埃森哲藥明康德、埃森哲、CoizantPoint.
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球功能服務供應商(FSP) 市場的各種策略矩陣來簡化決策。

IQVIA
- 公司簡介
- 產品/服務組合
- 財務表現
- 最新動態/更新
- 策略概述
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC（PPD）
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5962

Global Functional Service Providers (FSP) Market is estimated to be valued at USD 18.40 Bn in 2025 and is expected to reach USD 32.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 18.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 32.80 Bn

Figure. Functional Service Providers (FSP) Market Share (%), By Region 2025

Functional Service Providers (FSP) Market - IMG1

Functional service providers (FSPs) aim to manage different back-end and administrative functions on behalf of organizations enabling them to focus on their core business activities. They handle non-core but critical business functions such as finance and accounting, human resource management, procurement, and supply chain management among others. This allows client organizations to scale their operations cost effectively without having to invest in developing extensive in-house functional capabilities. They help improve operational efficiency and optimize costs. The market provides opportunities for enterprises to leverage specialized expertise and technologies for improving various functional processes.

Market Dynamics:

The growth of the functional service providers market growth is driven by the increasing adoption of outsourcing as a strategy for reducing operational costs and gaining access to specialized domain expertise. Many organizations look to work with FSPs to scale their operations flexibly according to changing business needs. The market sees restraints from concerns around loss of control over certain functions and risks related to over-dependence on external partners for critical activities. However, factors such as advancements in automation technologies and emergence of innovative business models are creating new opportunities in this space. Vendors are developing industry and function-specific solutions leveraging technologies like analytics, AI and blockchain. For instance, in September 2022, Triall, a blockchain-integrated eClinical platform provider, collaborated with Mayo Clinic researchers to advance clinical trial design and data management techniques. This collaboration represents an essential step forward in guiding a global transformation toward decentralized clinical research.

Key Features of the Study:

This report provides an in-depth analysis of the global functional service providers (FSP) market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global functional service providers (FSP) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include IQVIA, Parexel International Corporation, ICON plc, PRA Health Sciences, Covance Inc., Charles River Laboratories International Inc., Syneos Health, Pharmaceutical Product Development LLC (PPD), Medpace Holdings Inc., LabCorp, Wuxi AppTec, Accenture, Cognizant, Quanticate, and BioPoint Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global functional service providers (FSP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global functional service providers (FSP) market.

Detailed Segmentation:

Service Type:
- Clinical Trail Design and Monitoring
- Regulatory Affairs
- Data Management
- Pharmacovigilance and Drug Safety
- Biostatistics/Programming
- Medical Writing
- Others
Stage:
- Clinical Development
- Post Approval
Therapeutic Area:
- Oncology
- Cardiovascular
- Infectious Diseases
- Central Nervous System (CNS)
- Respiratory
- Immunology
- Gastrointestinal
- Others
End User:
- Biopharmaceutical Companies
- Medical Device Companies
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- IQVIA
- Parexel International Corporation
- ICON plc
- PRA Health Sciences
- Covance Inc.
- Charles River Laboratories International Inc.
- Syneos Health
- Pharmaceutical Product Development LLC (PPD)
- Medpace Holdings Inc.
- LabCorp
- Wuxi AppTec
- Accenture
- Cognizant
- Quanticate
- BioPoint Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Stage
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending by Country

4. Global Functional Service Providers (FSP) Market, By Service Type, 2020 - 2032 (USD BN)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Clinical Trial Design and Monitoring, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Regulatory Affairs, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Data Management, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Pharmacovigilance and Drug Safety, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Biostatistics/Programming, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Medical Writing, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Others, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)

5. Global Functional Service Providers (FSP) Market, By Stage, 2020 - 2032 (USD BN)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Clinical Development, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Post Approval, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)

6. Global Functional Service Providers (FSP) Market, By Therapeutic Area, 2020 - 2032 (USD BN)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Oncology, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Cardiovascular, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Infectious Diseases, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Central Nervous System (CNS), 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Respiratory, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Immunology, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Gastrointestinal, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Others, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)

7. Global Functional Service Providers (FSP) Market, By End User, 2020 - 2032 (USD BN)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Biopharmaceutical Companies, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Medical Device Companies, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)
Others, 2020 - 2032 (USD BN)
- Introduction
- Market Size and Forecast, 2020 - 2032, (USD BN)

8. Global Functional Service Providers (FSP) Market, By Region, 2020 - 2032 (USD BN)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, (USD BN)
- Market Y-o-Y Growth Comparison (%), 2020 - 2032, (USD BN)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Stage, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD BN)
- Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Stage, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD BN)
- Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Stage, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD BN)
- Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Stage, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD BN)
- Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
  - Brazil
  - Mexico
  - Argentina
  - Rest Of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Stage, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD BN)
- Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
  - GCC
  - Israel
  - Rest Of The Middle East
Africa

9. Company Profiles - Global Functional Service Providers (FSP) Market

IQVIA
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Parexel International Corporation
ICON plc
PRA Health Sciences
Covance Inc.
Charles River Laboratories International Inc.
Syneos Health
Pharmaceutical Product Development LLC (PPD)
Medpace Holdings Inc.
LabCorp
Wuxi AppTec
Accenture
Cognizant
Quanticate
BioPoint Inc.